1
|
Gallareta-Olivares G, Rivas-Sanchez A, Cruz-Cruz A, Hussain SM, González-González RB, Cárdenas-Alcaide MF, Iqbal HMN, Parra-Saldívar R. Metal-doped carbon dots as robust nanomaterials for the monitoring and degradation of water pollutants. Chemosphere 2023; 312:137190. [PMID: 36368530 DOI: 10.1016/j.chemosphere.2022.137190] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Revised: 10/27/2022] [Accepted: 11/05/2022] [Indexed: 06/16/2023]
Abstract
The contamination of the environment by domestic and industrial discharges is a relevant and persistent problem that needs novel solutions. Innovations in the detection, adsorption, and removal or in-situ degradation of toxic components are urgently required. Various effective techniques and materials have been proposed to address this problem, in which carbon dots (CDs) stand out because of their unique properties and low-cost and abundant nature. Their combination with different metals results in the enhancement of their innate properties. Metal-doped CDs have shown excellent results and competitive advantages in recent times. Considering the above useful critiques and CDs notable potentialities, this review discusses different approaches in detail to sense, adsorb, and photodegrade different pollutants in water samples. It was found that altering the electronic structure of CDs via metal doping has a great potential to enhance the optical, electrical, chemical, and magnetic capabilities of CDs, which in turn is beneficial for wastewater treatment.
Collapse
Affiliation(s)
| | - Andrea Rivas-Sanchez
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico
| | - Angelica Cruz-Cruz
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico
| | - Syed Makhdoom Hussain
- Department of Zoology, Government College University Faisalabad, Faisalabad, Punjab, 38000, Pakistan
| | - Reyna Berenice González-González
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico; Institute of Advanced Materials for Sustainable Manufacturing, Tecnologico de Monterrey, Monterrey, 64849, Mexico
| | - María Fernanda Cárdenas-Alcaide
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico; Institute of Advanced Materials for Sustainable Manufacturing, Tecnologico de Monterrey, Monterrey, 64849, Mexico
| | - Hafiz M N Iqbal
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico; Institute of Advanced Materials for Sustainable Manufacturing, Tecnologico de Monterrey, Monterrey, 64849, Mexico.
| | - Roberto Parra-Saldívar
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico; Institute of Advanced Materials for Sustainable Manufacturing, Tecnologico de Monterrey, Monterrey, 64849, Mexico.
| |
Collapse
|
2
|
Rivas-Sanchez A, Cruz-Cruz A, Gallareta-Olivares G, González-González RB, Parra-Saldívar R, Iqbal HMN. Carbon-based nanocomposite materials with multifunctional attributes for environmental remediation of emerging pollutants. Chemosphere 2022; 303:135054. [PMID: 35613636 DOI: 10.1016/j.chemosphere.2022.135054] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 05/02/2022] [Accepted: 05/19/2022] [Indexed: 05/27/2023]
Abstract
Carbon-based materials are among the most biosynthesized nanocomposites with excellent tunability and multifunctionality features, that other materials fail to demonstrate. Naturally occurring materials, such as alginate (Alg), can be combined and modified by linking the active moieties of various carbon-based materials of interest, such as graphene oxide (GO), carbon nanotubes (CNTs), and mesoporous silica nanocomposite (MSN), among others. Thus, several types of robust nanocomposites have been fabricated and deployed for environmental remediation of emerging pollutants, such as pharmaceutical compounds, toxic dyes, and other environmentally hazardous contaminants of emerging concern. Considering the above critiques and added features of carbon-based nanocomposites, herein, an effort has been made to spotlight the synergies of GO, CNTs, and MSN with Alg and their role in mitigating emerging pollutants. From the information presented in this work, it can be concluded that Alg is a material that has excellent potential. However, its use still requires further tests in different areas and other materials to carry out a holistic investigation that exploits its versatility for environmental remediation purposes.
Collapse
Affiliation(s)
- Andrea Rivas-Sanchez
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico
| | - Angelica Cruz-Cruz
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico
| | | | | | | | - Hafiz M N Iqbal
- Tecnologico de Monterrey, School of Engineering and Sciences, Monterrey, 64849, Mexico.
| |
Collapse
|
3
|
Cérbulo-Vázquez A, García-Espinosa M, Briones-Garduño JC, Arriaga-Pizano L, Ferat-Osorio E, Zavala-Barrios B, Cabrera-Rivera GL, Miranda-Cruz P, García de la Rosa MT, Prieto-Chávez JL, Rivero-Arredondo V, Madera-Sandoval RL, Cruz-Cruz A, Salazar-Rios E, Salazar-Rios ME, Serrano-Molina D, De Lira-Barraza RC, Villanueva-Compean AH, Esquivel-Pineda A, Ramirez-Montes de Oca R, Caldiño-Soto F, Ramírez-García LA, Flores-Padilla G, Moreno-Álvarez O, Guerrero-Avendaño GML, López-Macías C. The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients. PLoS One 2022; 17:e0264566. [PMID: 35901034 PMCID: PMC9333267 DOI: 10.1371/journal.pone.0264566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2021] [Accepted: 02/13/2022] [Indexed: 12/02/2022] Open
Abstract
Current medical guidelines consider pregnant women with COVID-19 to be a high-risk group. Since physiological gestation downregulates the immunological response to maintain “maternal-fetal tolerance”, SARS-CoV-2 infection may constitute a potentially threatening condition to both the mother and the fetus. To establish the immune profile in pregnant COVID-19+ patients, a cross-sectional study was conducted. Pregnant women with COVID-19 (P-COVID-19+; n = 15) were analyzed and compared with nonpregnant women with COVID-19 (NP-COVID-19+; n = 15) or those with physiological pregnancy (P-COVID-19-; n = 13). Serological cytokine and chemokine concentrations, leucocyte immunophenotypes, and mononuclear leucocyte responses to polyclonal stimuli were analyzed in all groups. Higher concentrations of serological TNF-α, IL-6, MIP1b and IL-4 were observed within the P-COVID-19+ group, while cytokines and chemokines secreted by peripheral leucocytes in response to LPS, IL-6 or PMA-ionomicin were similar among the groups. Immunophenotype analysis showed a lower percentage of HLA-DR+ monocytes in P-COVID-19+ than in P-COVID-19- and a higher percentage of CD39+ monocytes in P-COVID-19+ than in NP-COVID-19+. After whole blood polyclonal stimulation, similar percentages of T cells and TNF+ monocytes between groups were observed. Our results suggest that P-COVID-19+ elicits a strong inflammatory response similar to NP-COVID19+ but also displays an anti-inflammatory response that controls the ATP/adenosine balance and prevents hyperinflammatory damage in COVID-19.
Collapse
Affiliation(s)
- A. Cérbulo-Vázquez
- Departamento de Medicina Genómica, Hospital General de México “Dr. Eduardo Liceaga”, Ciudad de México, México
- * E-mail: (ACV); , (CLM)
| | - M. García-Espinosa
- Servicio de Complicaciones de la Segunda Mitad del Embarazo, UMAE Hospital de Gineco-Obstetricia No. 4 “Dr. Luis Castelazo Ayala”. Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México
| | - J. C. Briones-Garduño
- Dirección de Medicina Aguda, Diagnóstico y Tratamiento, Hospital General de México “Dr. Eduardo Liceaga”, Ciudad de México, México
| | - L. Arriaga-Pizano
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - E. Ferat-Osorio
- División de Investigación, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - B. Zavala-Barrios
- Dirección de Medicina Aguda, Diagnóstico y Tratamiento, Hospital General de México “Dr. Eduardo Liceaga”, Ciudad de México, México
| | - G. L. Cabrera-Rivera
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - P. Miranda-Cruz
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - M. T. García de la Rosa
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - J. L. Prieto-Chávez
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
- Centro de Instrumentos, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - V. Rivero-Arredondo
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - R. L. Madera-Sandoval
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - A. Cruz-Cruz
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - E. Salazar-Rios
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - M. E. Salazar-Rios
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - D. Serrano-Molina
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - R. C. De Lira-Barraza
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - A. H. Villanueva-Compean
- Medicina Interna, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - A. Esquivel-Pineda
- Medicina Interna, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - R. Ramirez-Montes de Oca
- Medicina Interna, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - F. Caldiño-Soto
- División Obstetricia, UMAE Hospital de Gineco-Obstetricia No. 4 “Dr. Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México
| | - L. A. Ramírez-García
- Dirección Médica, UMAE Hospital de Gineco-Obstetricia No. 4 “Dr. Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México
| | - G. Flores-Padilla
- Medicina Interna, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
| | - O. Moreno-Álvarez
- Dirección Médica, UMAE Hospital de Gineco-Obstetricia No. 4 “Dr. Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México
| | | | - C. López-Macías
- Unidad de Investigación Médica en Inmunoquímica, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI. IMSS, Ciudad de México, México
- Visiting Professor of Immunology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- * E-mail: (ACV); , (CLM)
| |
Collapse
|